Aptevo Therapeutics DSO Ratio 2011-2026 | APVO

Annual DSO Ratio Aptevo Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	79	82.6	53.3	42.9	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
82.6	42.9	64.5

Quarterly DSO Ratio Aptevo Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	77.5	81.7	71.6	-	81.8	69.8	82.5	-	31.6	18.1	52.1	3.19	74.4	38.4	60.7	71.1	89.8	41.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
89.8	3.19	59.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 215.54	-1.16 %	$ 5 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	103	$ 3.88	-1.27 %	$ 415 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.23	-	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.18	-2.97 %	$ 109 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	9.68	$ 0.71	17.15 %	$ 8.13 M	Israel
CytomX Therapeutics CTMX	12.3	$ 4.24	-4.83 %	$ 585 M	USA
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Genmab A/S GMAB	97.9	$ 25.81	0.51 %	$ 16.6 B	Danmark
Aytu BioScience AYTU	150	$ 2.65	0.76 %	$ 16.6 M	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Eton Pharmaceuticals ETON	39.1	$ 22.97	-3.53 %	$ 618 M	USA
Exelixis EXEL	43.4	$ 41.57	0.39 %	$ 11.3 B	USA
Fortress Biotech FBIO	80.5	$ 2.92	-2.01 %	$ 60.7 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.31	-2.49 %	$ 826 M	Canada